TIM
TEVA icon

Tortoise Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Tortoise Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-711
Closed -$6K – 792
2022
Q3 		$6K Buy
+711
New +$6.29K ﹤0.01% 594
2016
Q1 		– Sell
-338
Closed -$22K – 431
2015
Q4 		$22K Buy
+338
New +$20.9K 0.01% 261
2014
Q3 		– Sell
-500
Closed -$26K – 422
2014
Q2 		$26K Buy
+500
New +$25.6K 0.01% 258

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Tortoise Investment Management's TEVA Position: Q4 2022 in Review

Tortoise Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2022, closing a stake of 711 shares — an estimated $6K sold.

Tortoise Investment Management first reported a position in TEVA in Q2 2014 and held it in 3 quarters. The position peaked at $26K in Q2 2014. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Tortoise Investment Management reported no remaining Teva Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Tortoise Investment Management sold 711 Teva Pharmaceuticals shares in Q4 2022, an estimated $6K.
  • Tortoise Investment Management first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 3 quarters.
  • Tortoise Investment Management's Teva Pharmaceuticals position peaked at $26K in Q2 2014.
  • 422 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Tortoise Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.